Insights

20 October 2025

Life sciences A to Z - O is for (Employee Share) Options

01 June 2020

Stephenson Harwood advises Oxford Biomedica on COVID-19 vaccine with AstraZeneca

Law firm Stephenson Harwood LLP has advised Oxford Biomedica plc (Oxford Biomedica), a gene and cell therapy company, on a Clinical and Commercial Supply Agreement with AstraZeneca UK Ltd (AstraZeneca).

Documents disclosed to the EMA as part of an MA application process are not presumed to be confidential

Read more Insight

Insights and news

Stephenson Harwood advises Oxford Biomedica on COVID-19 vaccine with AstraZeneca

How to practise safe working in labs and research facilities

Antitrust: Impact of COVID-19 on life sciences

Biotech listings in Hong Kong

Documents disclosed to the EMA as part of an MA application process are not presumed to be confidential